[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Simmons, 1995 - Google Patents

Variation of the Mycoplasma pulmonis V-1 antigen: A model for the mechanism of phase switching between phenotypes

Simmons, 1995

View PDF
Document ID
14079262261343340154
Author
Simmons W
Publication year

External Links

Snippet

The mycoplasmas are causative agents of diseases of man and animals. The diseases that they cause are often chronic in nature. The mechanisms by which they establish themselves in their hosts are currently being elucidated. Potentially contributing to their chronicity is the …
Continue reading at digitalcommons.library.uab.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)

Similar Documents

Publication Publication Date Title
RAZIN et al. Mycoplasma adhesion
Jeyaseelan et al. Role of Mannheimia haemolytica leukotoxin in the pathogenesis of bovine pneumonic pasteurellosis
Razin The genus Mycoplasma and related genera (class Mollicutes)
Frey et al. RTX toxins in Pasteurellaceae
van den Bosch et al. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs
JP2008022856A (en) Nucleic acid and protein derived from streptococcus pneumoniae
HU228700B1 (en) Streptococcus suis vaccines and diagnostic tests
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
US8324354B2 (en) Environmentally regulated genes of Streptococcus suis
JP2008067707A (en) Lkp pilin structural gene and operon of nontypable haemophilus influenzae
CN110582296B (en) Attenuation of bacterial virulence by attenuation of bacterial folate transport
TWI335935B (en) Anti-bacterial vaccine compositions
Lo Genetic analysis of virulence factors of Mannheimia (Pasteurella) haemolytica A1
JP3124753B2 (en) Influenza vaccine and diagnostic methods
RU2252224C2 (en) Peptide with neisseria meningitidis antigene activity, polynucleotide encoding the same, vaccine for prevention and treatment of diseases and conditions induced by neisseria meningitidis, (variants), antibody coupling with said peptide
Röske et al. Phase variation among major surface antigens of Mycoplasma penetrans
JP4141496B2 (en) Hemophilus adhesion protein
Tatum et al. Sialic acid uptake is necessary for virulence of Pasteurella multocida in turkeys
CA2516971A1 (en) Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
Adler et al. The genus leptospira
Simmons Variation of the Mycoplasma pulmonis V-1 antigen: A model for the mechanism of phase switching between phenotypes
PT2256185E (en) Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof
Gorton Physical mapping of the genome and elucidation of variable proteins of Mycoplasma gallisepticum
JP2001504335A (en) Lactoferrin-binding protein of Streptococcus uberis
Ludu Characterization of PdpD, a Francisella pathogenicity island protein.